BBIO BridgeBio Pharma, Inc. logo

BBIO BridgeBio Pharma, Inc.

Healthcare
$67.73-2.01%ClosedMarket Cap: $13.27B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

474

13F Shares

191,063,799

Ownership %

100.3%

New Positions

99

Increased Positions

259

Closed Positions

58

Reduced Positions

138

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
HELXFranklin Genomic Advancements ETF12,1924.12%
CANCTema Oncology ETF91,0813.97%
HRTSTema Cardiovascular and Metabolic ETF20,5952.87%
PTHInvesco Dorsey Wright Healthcare Momentum ETF38,3242.37%
BBPVirtus Biotech ETF11,2341.53%
CVRTCalamos Convertible Equity Alternative ETF164,0001.50%
FSMLFranklin Small Cap Enhanced ETF21,9251.45%
ANOGX850,9781.33%
JSMLJanus Henderson Small Cap Growth Alpha ETF49,2221.31%
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETF136,2961.22%
IPORenaissance IPO ETF127,6751.20%
XBI1,186,8161.19%
IBBQInvesco Nasdaq Biotechnology ETF11,4011.13%
IBBiShares Biotechnology ETF1,238,6871.10%
PDPInvesco Dorsey Wright Momentum ETF171,1720.96%
GSCGoldman Sachs Small Cap Equity ETF19,3930.91%
LABUDirexion Daily S&P Biotech Bull 3X ETF59,4450.86%
NLO1,294,0720.77%
IWOiShares Russell 2000 Growth ETF1,294,0720.77%
QQQJInvesco NASDAQ Next Gen 100 ETF87,0050.74%